Evidence map›Paper›PMID 28343294›Full record

ArticleJournal of molecular neuroscience : MN2017

Neuroprotective Role of Exogenous Brain-Derived Neurotrophic Factor in Hypoxia-Hypoglycemia-Induced Hippocampal Neuron Injury via Regulating Trkb/MiR134 Signaling.

Weidong Huang, Facai Meng, Jie Cao, Xiaobin Liu, Jie Zhang, Min Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The Effects of Yuan-Zhi Decoction and Its Active Ingredients in BothEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Weidong HuangDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China. weidonghuangsx@163.com.
Facai MengDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China.
Jie CaoDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China.
Xiaobin LiuDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China.
Jie ZhangDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China.
Min LiDepartment of Neurosurgery, Shaanxi Provincial People's Hospital, NO 256, Youyi West Road, Xi'an, 710068, China.
Shaanxi Provincial People's Hospital · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxic-ischemic brain injury is an important cause of neonatal mortality and morbidity. Brain-derived neurotrophic factor (BDNF) has been reported to play a neuroprotective role in hypoxic-ischemic brain injury; however, the specific effects and mechanism of BDNF on hypoxic-hypoglycemic hippocampal neuron injury remains unknown. The current study investigated the action of BDNF in regulating cerebral hypoxic-ischemic injury by simulating hippocampal neuron ischemia and hypoxia. We found that BDNF, p-Trkb, and miR-134 expression levels decreased, and that exogenous BDNF increased survival and reduced apoptosis in hypoxic-hypoglycemic hippocampal neurons. The results also show that BDNF inhibits MiR-134 expression by activating the TrkB pathway. Transfection with TrkB siRNA and pre-miR-134 abrogated the neuroprotective role of BDNF in hypoxic-hypoglycemic hippocampal neurons. Our results suggest that exogenous BDNF alleviates hypoxic-ischemic brain injury through the Trkb/MiR-134 pathway. These findings may help to identify a potential therapeutic agent for the treatment of hypoxic-ischemic brain injury.

Indexed as

AnimalsApoptosisBrain-Derived Neurotrophic FactorCell HypoxiaCells, CulturedGlucoseHippocampusMicroRNAsNeuronsNeuroprotective AgentsOxygenRatsReceptor, trkBSignal TransductionBrain-Derived Neurotrophic FactorGlucoseMicroRNAsMIRN134 microRNA, ratNeuroprotective AgentsNtrk2 protein, ratOxygenReceptor, trkBBDNFhippocampal neuronHypoxic–ischemic brain injurymiR-134TrkB

Identifiers

PMID28343294
OpenAlexW2602681140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.